Silver nanoparticles combat Salmonella Typhimurium: suppressing intracellular infection and activating dendritic cells

Jiahao Gong,Xingxing Cheng,Jinjiao Zuo,Yan Zhang,Jian Lin,Moxin Liu,Yan Jiang,Yunfeng Long,Hongbin Si,Xiuge Gao,Dawei Guo,Ning Gu

DOI: https://doi.org/10.1016/j.colsurfb.2023.113307

2023-04-12

Abstract:Salmonella Typhimurium (ST) can hide inside cells, avoid antibiotic therapy and being killed by host's immune system to cause persistent infection in humans and animals. Metal nanoparticles are regarded as an alternative to overcome the above limitations, silver nanoparticles especially have been applied in combating drug-resistant bacteria. However, the therapeutic effects of silver nanoparticles against intracellular infection and their impacts on host immunity remain an area of further investigation. In this work, we synthesized Ganoderma extract-capped silver nanoparticles () and explored the therapeutic potential and immune adjuvant effects of against intracellular ST. Firstly, had a small particle size of 35.52±7.46 nm, good stability, and biocompatibility. Then, effectively entered RAW 264.7 cells, suppressed intracellular ST infection. Furthermore, activated mouse dendritic cells (DCs) in vitro , evidenced by increased phenotypic markers (CD80/CD86/CD40/major compatibility complex II (MHCII)) expression and cytokine and chemokine (interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), chemokine (C-C motif) ligand 2 (CCL-2), and chemokine (C-C motif) receptor-7 (CCR-7)) transcription. More notably, the combination of with inactivated ST recruited intestinal DCs to mitigate ST infection in mice, evidenced by decreased body weight loss and bacterial loads in the tissues (liver, jejunum, and colon), and improved platelets count. The above findings indicate that has the potential as an alternative nano-antibiotic against intracellular ST infection.

materials science, biomaterials,biophysics,chemistry, physical